m6A-centered Drug Response Information
General Information of the Drug (ID: M6ADRUG0212)
| Name |
MM-102
|
||||
|---|---|---|---|---|---|
| Synonyms |
MM-102, 1417329-24-8, HMTase Inhibitor IX, N-[bis(4-fluorophenyl)methyl]-1-[[(2S)-5-(diaminomethylideneamino)-2-[[2-ethyl-2-(2-methylpropanoylamino)butanoyl]amino]pentanoyl]amino]cyclopentane-1-carboxamide, MM102, (S)-N-(Bis(4-fluorophenyl)methyl)-1-(2-(2-ethyl-2-isobutyramidobutanamido)-5-guanidinopentanamido)cyclopentanecarboxamide, CHEMBL3883592, SCHEMBL12035529, CHEBI:233480, BDBM200723, GLXC-05980, BCP11764, EX-A1503, s7265, AKOS030526507, CCG-270356, MM-102, NCGC00351775-01, AC-36316, DA-65547, HY-12220, TS-09297, US9233086, 10L, SW220028-1, G14355, BRD-K68474068-001-01-8, cyclopentanecarboxamide, 1-[[(2S)-5-[(aminoiminomethyl)amino]-2-[[2-ethyl-2-[(2-methyl-1-oxopropyl)amino]-1-oxobutyl]amino]-1-oxopentyl]amino]-N-[bis(4-fluorophenyl)methyl]-, N-[bis(4-fluorophenyl)methyl]-1-[(2S)-5-carbamimidamido-2-[2-ethyl-2-(2-methylpropanamido)butanamido]pentanamido]cyclopentane-1-carboxamide
Click to Show/Hide
|
||||
| Structure |
 |
||||
|
3D MOL
|
|||||
| Formula |
C35H49F2N7O4
|
||||
| InChI |
InChI=1S/C35H49F2N7O4/c1-5-34(6-2,43-29(45)22(3)4)31(47)41-27(10-9-21-40-33(38)39)30(46)44-35(19-7-8-20-35)32(48)42-28(23-11-15-25(36)16-12-23)24-13-17-26(37)18-14-24/h11-18,22,27-28H,5-10,19-21H2,1-4H3,(H,41,47)(H,42,48)(H,43,45)(H,44,46)(H4,38,39,40)/t27-/m0/s1
|
||||
| InChIKey |
RZKSQRIPRKWVBU-MHZLTWQESA-N
|
||||
| PubChem CID | |||||
Full List of Crosstalk(s) between m6A Modification and Epigenetic Regulation Related to This Drug
| In total 1 item(s) under this drug | ||
| Crosstalk ID: M6ACROT03063 | ||
| m6A Regulator | Methyltransferase-like 14 (METTL14) | |
| m6A Target | HOX transcript antisense RNA (HOTAIR) | |
| Epigenetic Regulator | Lysine-specific histone demethylase 1A (KDM1A) | |
| Regulated Target | Histone H3 lysine 4 monomethylation (H3K4me1) | |
| Crosstalk relationship | m6A → Histone modification | |
| Disease | Disorders due to use of opioids | |